All Season Financial Advisors, Inc. Abb Vie Inc. Transaction History

All Season Financial Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $164,710 - $189,689	1,139 Added 44.97%	3,672 $585,000
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $1,244 - $1,492	-9 Reduced 0.35%	2,533 $409,000
Q3 2022 Oct 21, 2022	SELL	$134.21 - $153.93 $3,221 - $3,694	-24 Reduced 0.94%	2,542 $341,000
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $76,379 - $97,102	-555 Reduced 17.78%	2,566 $393,000
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $9,634 - $11,953	-73 Reduced 2.29%	3,121 $506,000
Q4 2021 Jan 25, 2022	BUY	$107.43 - $135.93 $343,131 - $434,160	3,194 New	3,194 $432,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of All Season Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on All Season Financial Advisors, Inc. with notifications on news.